Skip to main content
. 2022 Feb 15;12(2):e049493. doi: 10.1136/bmjopen-2021-049493

Table 1.

Guidelines for substitution with VWF-containing concentrate in VWD according to Dutch national guidelines

Indication Target levels
Dental extraction FVIII:C and VWF:Act>0.50 IU/mL
Surgery Prior to surgery and 36 hours postoperatively FVIII:C and VWF:Act>0.80 IU/mL
Major surgery FVIII:C>0.50 IU/mL during 7–10 days
Minor surgery FVIII:C>0.50 IU/mL during 3 days and >0.30 IU/mL during 4–7 days

FVIII:C, Factor VIII activity; VWD, Von Willebrand disease; VWF, Von Willebrand factor.